Literature DB >> 16895255

The prevalence of multiple sleep-onset REM periods in a population-based sample.

Meeta Singh1, Christopher L Drake, Thomas Roth.   

Abstract

STUDY
OBJECTIVE: The presence of 2 or more sleep-onset rapid eye movement periods (SOREMPs) on a Multiple Sleep Latency Test (MSLT) has been used as 1 of the criteria for the diagnosis of narcolepsy and is thought to be specific to this disorder. However, previous studies have shown the prevalence of SOREMPS in healthy volunteers and apneic patients to be higher than expected. The present study determined the prevalence of 2 or more SOREMPs in a representative sample of the population from southeast Michigan and investigated potential associations with other sleep-related variables.
DESIGN: Cross-sectional laboratory-based analysis. SETTINGS: Sleep disorders clinic. PARTICIPANTS: Population-based sample.
INTERVENTIONS: N/A. MEASUREMENTS: A population-based sample of 333 subjects was assessed by nocturnal polysomnography and daytime MSLT (5 naps), and an additional 206 subjectively sleepy people were also assessed (total = 539). Sample demographics were comparable to the 2000 census. Epworth Sleepiness Scale scores were also determined. Groups were formed based on a median split of each sleep variable (Epworth Sleepiness Scale, MSLT, total sleep time from nocturnal polysomnography) for comparisons of SOREMPs in each group.
RESULTS: The prevalence of 2 or more SOREMPs was 3.9%. Only mean sleep latency on the MSLT was a discriminator for the presence of 2 or more SOREMPs (short latency = 6.3%, long latency = 1.9%, p < .05). Among the subjects who had an MSLT of 5 minutes or less (an indicator of a pathologic level of sleepiness), 9.5% had 2 or more SOREMPS.
CONCLUSIONS: The overall prevalence of 2 or more SOREMPs in our sample is 3.9%. Interestingly, of the variables assessed (MSLT, Epworth Sleepiness Scale, and total sleep time from nocturnal polysomnography), objective sleepiness, as determined by the MSLT, was the only measure significantly associated with 2 or more SOREMPs. Therefore, subpopulations with excessive sleepiness (eg, shift workers, young adults, patients with apnea) are likely to have a greater prevalence of SOREMPs.

Entities:  

Mesh:

Year:  2006        PMID: 16895255     DOI: 10.1093/sleep/29.7.890

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  23 in total

1.  Narcolepsy in African Americans.

Authors:  Makoto Kawai; Ruth O'Hara; Mali Einen; Ling Lin; Emmanuel Mignot
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

2.  Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy.

Authors:  Yaping Liu; Jihui Zhang; Venny Lam; Crover Kwok Wah Ho; Junying Zhou; Shirley Xin Li; Siu Ping Lam; Mandy Wai Man Yu; Xiangdong Tang; Yun-Kwok Wing
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

3.  Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders.

Authors:  Rohit Budhiraja; Thomas Roth; David W Hudgel; Pooja Budhiraja; Christopher L Drake
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

4.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Authors:  Christian R Baumann; Emmanuel Mignot; Gert Jan Lammers; Sebastiaan Overeem; Isabelle Arnulf; David Rye; Yves Dauvilliers; Makoto Honda; Judith A Owens; Giuseppe Plazzi; Thomas E Scammell
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

Review 5.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

Review 6.  The neurophysiological basis of excessive daytime sleepiness: suggestions of an altered state of consciousness.

Authors:  P K Hitchcott; D Menicucci; S Frumento; A Zaccaro; A Gemignani
Journal:  Sleep Breath       Date:  2019-05-28       Impact factor: 2.816

7.  Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study.

Authors:  Surilla Randall; Chris-Ellyn Johanson; Manuel Tancer; Timothy Roehrs
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

8.  The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese.

Authors:  Lei Chen; S Y Y Fong; Ching W Lam; Nelson L S Tang; Margaret H L Ng; Albert M Li; C K W Ho; Suk-Hang Cheng; Kin-Mang Lau; Yun Kwok Wing
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

9.  The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study.

Authors:  Chad Ruoff; Fabio Pizza; Lynn Marie Trotti; Karel Sonka; Stefano Vandi; Joseph Cheung; Swaroop Pinto; Mali Einen; Narong Simakajornboon; Fang Han; Paul Peppard; Sona Nevsimalova; Giuseppe Plazzi; David Rye; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

10.  Modafinil in the treatment of excessive sleepiness.

Authors:  Jonathan R L Schwartz
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.